Financial incentives for hypertension control in China (FIHCC study)

Financial incentives for hypertension control among community-based hypertensive populations: a multi-center, randomized controlled trial

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN13467677

Enrollment

400

Registered

2019-05-16

Start date

2019-08-01

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension Circulatory System

Interventions

We will recruit 400 eligible subjects and assign the subjects 1:1 to the intervention and control groups by block randomization, with 200 in each group. Participants in control group will receive inte

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Aged 35 - 75 years 2. Uncontrolled hypertensive patients (SBP/DBP = 140/90mmHg) 3. Have WeChat and use skillfully 4. Local residents, who live in local places for more than 12 months 5. Voluntarily joined and signed informed consents

Exclusion criteria

Exclusion criteria: 1. Pregnant women or women who are planning to become pregnant in the next year 2. Plans to move from the neighborhood in the next year 3. Malignant tumors or severe liver, kidney dysfunction 4. Can not be proficient in using WeChat 5. Secondary hypertension patients 6. Disagree to participate in the study or cannot give the informed consent

Design outcomes

Primary

Measure	Time frame
Systolic blood pressure at the baseline and after 1, 3, 6, and 12 months	—

Secondary

Measure	Time frame
1. Diatolic blood pressure measured using blood pressure monitors at the baseline, and after 1, 3, 6 and 12 months 2. The proportion of hypertension control (BP <140/90 mmHg) at 1, 3, 6, and 12 months 3. Medication adherence at the baseline, and after 1, 3, 6, and 12 months 4. Body mass index assessed by dividing weight in kg by height in metres at the baseline, and after 1, 3, 6, and 12 months 5. Physical activity at the baseline, and after 1, 3, 6, and 12 months 6. Counseling frequency at the baseline, and after 1, 3, 6, and 12 months 7. Counseling content at the baseline, and after 1, 3, 6, and 12 months 8. Number of steps in WeChat at the baseline, and after 1, 3, 6, and 12 months 9. Pulmonary function at the baseline and after 12 months 10. Pulse wave velocity at the baseline and after 12 months 11. Ankle brachial index at the baseline and after 12 months 12. Cost-effectiveness	—

Measure

Time frame

1. Diatolic blood pressure measured using blood pressure monitors at the baseline, and after 1, 3, 6 and 12 months 2. The proportion of hypertension control (BP <140/90 mmHg) at 1, 3, 6, and 12 months 3. Medication adherence at the baseline, and after 1, 3, 6, and 12 months 4. Body mass index assessed by dividing weight in kg by height in metres at the baseline, and after 1, 3, 6, and 12 months 5. Physical activity at the baseline, and after 1, 3, 6, and 12 months 6. Counseling frequency at the baseline, and after 1, 3, 6, and 12 months 7. Counseling content at the baseline, and after 1, 3, 6, and 12 months 8. Number of steps in WeChat at the baseline, and after 1, 3, 6, and 12 months 9. Pulmonary function at the baseline and after 12 months 10. Pulse wave velocity at the baseline and after 12 months 11. Ankle brachial index at the baseline and after 12 months 12. Cost-effectiveness

—

Countries

China

Contacts

Public ContactYundi Jiao

jiaoyundi1987@163.com86-18940252778

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 28, 2026